Clinical significance and outcome of polymicrobial Staphylococcus aureus bacteremia

Journal of Infection

Volumn 65, Issue 2, 2012, Pages 119-127

  Park, Seong Yeon ^a,c   Park, Ki Ho ^a,b   Bang, Kyung Mi ^a   Chong, Yong Pil ^a,b   Kim, Sung Han ^a   Lee, Sang Oh ^a   Choi, Sang Ho ^a   Jeong, Jin Young ^a,b   Woo, Jun Hee ^a   Kim, Yang Soo ^a,b  

^a University of Ulsan College of Medicine   (South Korea)

^b University of Ulsan   (South Korea)

^c Dongguk University Ilsan Hospital   (South Korea)

Author keywords

Polymicrobial bacteremia; Staphylococcus aureus

Indexed keywords

ANTIINFECTIVE AGENT;

ABDOMINAL INFECTION; ANTIMICROBIAL THERAPY; ARTICLE; BACILLUS; BACTERIUM CULTURE; BACTERIUM ISOLATE; BLOOD CULTURE; CATHETER INFECTION; CLINICAL ARTICLE; CLINICAL FEATURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; COHORT ANALYSIS; CONTROLLED STUDY; CORYNEBACTERIUM; DISEASE SEVERITY; HUMAN; INCIDENCE; MIXED INFECTION; MONOMICROBIAL STAPHYLOCOCCAL BACTEREMIA; MORTALITY; NEUTROPENIA; OUTCOME ASSESSMENT; POLYMICROBIAL STAPHYLOCOCCAL BACTEREMIA; RISK FACTOR; STAPHYLOCOCCAL BACTEREMIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; BLOOD; COHORT STUDIES; COINFECTION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84862989428     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2012.02.015     Document Type: Article

References (45)

1. Hermans P.E., Washington J.A. Polymicrobial bacteremia. Ann Intern Med 1970, 73:387-392.
2. Roselle G.A., Watanakunakorn C. Polymicrobial bacteremia. JAMA 1979, 242:2411-2413.
3. Cooper G.S., Havlir D.S., Shlaes D.M., Salata R.A. Polymicrobial bacteremia in the late 1980s: predictors of outcome and review of the literature. Medicine (Baltimore) 1990, 69:114-123.
4. Bodey G.P., Nies B.A., Freireich E.J. Multiple organism septicemia in acute leukemia; analysis of 54 episodes. Arch Intern Med 1965, 116:266-272.
5. Kiani D., Quinn E.L., Burch K.H., Madhavan T., Saravolatz L.D., Neblett T.R. The increasing importance of polymicrobial bacteremia. JAMA 1979, 242:1044-1047.
6. Rello J., Quintana E., Mirelis B., Gurgui M., Net A., Prats G. Polymicrobial bacteremia in critically ill patients. Intensive Care Med 1993, 19:22-25.
7. Downes K.J., Metlay J.P., Bell L.M., McGowan K.L., Elliott M.R., Shah S.S. Polymicrobial bloodstream infections among children and adolescents with central venous catheters evaluated in ambulatory care. Clin Infect Dis 2008, 46:387-394.
8. Reuben A.G., Musher D.M., Hamill R.J., Broucke I. Polymicrobial bacteremia: clinical and microbiologic patterns. Rev Infect Dis 1989, 11:161-183.
9. Kim S.H., Park W.B., Lee K.D., Kang C.I., Bang J.W., Kim H.B., et al. Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 2004, 54:489-497.
10. Kim S.H., Kim K.H., Kim H.B., Kim N.J., Kim E.C., Oh M.D., et al. Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 2008, 52:192-197.
11. Nolan C.M., Beaty H.N. Staphylococcus aureus bacteremia. Current clinical patterns. Am J Med 1976, 60:495-500.
12. Cluff L.E., Reynolds R.C., Page D.L., Breckenridge J.L. Staphylococcal bacteremia and altered host resistance. Ann Intern Med 1968, 69:859-873.
13. Aliaga L., Mediavilla J.D., Llosa J., Miranda C., Rosa-Fraile M. Clinical significance of polymicrobial versus monomicrobial bacteremia involving Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis 2000, 19:871-874.
14. Sutter D., Stagliano D., Braun L., Williams F., Arnold J., Ottolini M., et al. Polymicrobial bloodstream infection in pediatric patients: risk factors, microbiology, and antimicrobial management. Pediatr Infect Dis J 2008, 27:400-405.
15. Bizzarro M.J., Dembry L., Baltimore R.S., Gallagher P.G. Mathced case-control analysis of polymicrobial bloodstream infection in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2008, 29:914-920.
16. de Kraker M.E., Wolkewitz M., Davey P.G., Koller W., Berger J., Nagler J., et al. Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillin-resistant Staphylococcus aureus bloodstream infections. Antimicrob Agents Chemother 2011, 55:1598-1605.
17. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
18. McCabe W.R., Jackson G.G. Gram-negative bacteremia. I. Etiology and ecology. Arch Intern Med 1962, 110:847-855.
19. Paterson D.L., Ko W.C., Von Gottberg A., Mohapastra S., Casellas M.J., Goossens H., et al. International prospective study of Klebsiella pneumoniae Bacteremia: implications of extended-spectrum β-lactamase production in nosocomial infections. Ann Intern Med 2004, 140:26-32.
20. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20:864-874.
21. Weinstein M.P., Reller L.B., Murphy J.R., Lichtenstein K.A. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis 1983, 5:35-53.
22. Friedman N.D., Kaye K.S., Stout J.E., McGarry S.A., Trivette S.L., Briggs J.P., et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002, 137:791-797.
23. Raad I., Hanna H.A., Alakech B., Chatzinikolaou I., Johnson M.M., Tarrand J. Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections. Ann Intern Med 2004, 140:18-25.
24. Harbarth S., Rutschmann O., Sudre P., Pittet D. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med 1998, 158:182-189.
25. Kim S.H., Park W.B., Lee K.D., Kang C.I., Kim H.B., Oh M.D., et al. Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci. Clin Infect Dis 2003, 37:794-799.
26. Culver D.H., Horan T.C., Gaynes R.P., et al. Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance System. Am J Med 1991, 91:152S-157S.
27. Li J.S., Sexton D.J., Mick N., Nettles R., Fowler V.G., Ryan T., et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000, 30:633-638.
28. Jensen A.G., Wachmann C.H., Espersen F., Scheibel J., Skinhoj P., Frimodt-Moller N. Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases. Arch Intern Med 2002, 162:25-32.
29. Soriano A., Martinez J.A., Mensa J., Marco F., Almela M., Moreno-Martinez A., et al. Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia. Clin Infect Dis 2000, 30:368-373.
30. Siegman-Igra Y., Schwartz D., Konforti N., Perluk C., Rozin R.R. Septicemia from biliary tract infection. Arch Surg 1988, 123:366-368.
31. Rolston K.V., Bodey G.P., Safdar A. Polymicrobial infection in patients with cancer: an underappreciated and underreported entity. Clin Infect Dis 2007, 45:228-233.
32. Awada A., van der Auwera P., Meunier F., Daneau D., Klastersky J. Streptococcal and enterococcal bacteremia in patients with cancer. Clin Infect Dis 1992, 15:33-48.
33. Gullberg R.M., Homann S.R., Phair J.P. Enterococcal bacteremia: analysis of 75 episodes. Rev Infect Dis 1989, 11:74-85.
34. Maki D.G., Agger W.A. Enterococcal bacteremia: clinical features, the risk of endocarditis, and management. Medicine (Baltimore) 1988, 67:248-269.
35. Gray J., Marsh P.J., Stewart D., Pedler S.J. Enterococcal bacteraemia: a prospective study of 125 episodes. J Hosp Infect 1994, 27:179-186.
36. Kang C.I., Kim S.H., Park W.B., Lee K.D., Kim H.B., Kim E.C., et al. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 2005, 49:760-766.
37. Ibrahim E.H., Sherman G., Ward S., Fraser V.J., Kollef M.H. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000, 118:146-155.
38. Kim S.H., Park W.B., Lee C.S., Kang C.I., Bang J.W., Kim H.B., et al. Outcome of inappropriate empirical antibiotic therapy in patients with Staphylococcus aureus bacteraemia: analytical strategy using propensity scores. Clin Microbiol Infect 2006, 12:13-21.
39. Feld R. Vancomycin as part of initial empirical antibiotic therapy for febrile neutropenia in patients with cancer: pros and cons. Clin Infect Dis 1999, 29:503-507.
40. Fowler V.G., Oslen M.K., Corey G.R., Woods C.W., Cabell C.H., Reller L.B., et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 2003, 163:2066-2072.
41. Gopal A.K., Fowler V.G., Shah M., et al. Prospective analysis of Staphylococcus aureus bacteremia in nonneutropenic adults with malignancy. J Clin Oncol 2000, 18:1110-1115.
42. Pedersen G., Schonheyder H.C. Patients with bacteremia dying before notification of positive blood cultures: a 3-year clinical study. Scand J Infect Dis 1997, 29:169-173.
43. McGreglr J.C., Rich S.E., Harris A.D., Perencevich E.N., Osih R., Lodise T.P., et al. A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients. Clin Infect Dis 2007, 45:329-337.
44. Choi S.H., Lee J.E., Park S.J., Choi S.H., Lee S.O., Jeong J.Y., et al. Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC ß-lactamase: implications for antibiotic use. Antimicrob Agents Chemother 2008, 52:995-1000.
45. Park D.H., Jang J.W., Lee S.S., Seo D.W., Lee S.K., Kim M.H. EUS-guided biliary drainage with transluminal stenting after failed ERCP: predictors of adverse events and long-term results. Gastrointest Endosc 2011, 74:1276-1284.